3 Warning Signs From Aphria's Abysmal Earnings Report

Much to the chagrin of Aphria's (NASDAQ: APHA) shareholders -- including yours truly -- Monday morning's third-quarter earnings report was chock-full of not-so-great news. Mere months ahead of its planned merger with Tilray (NASDAQ: TLRY), the Canadian cannabis company is still struggling to show the market that its core business initiatives are sound. For those considering a purchase of Aphria before the merger closes, the update has several stark warnings that shouldn't be ignored.